Oxyrane

Enzyme replacement therapies (ERT) to treat lysosomal storage diseases.

placeManchester, England, United Kingdom calendar_todayFounded 2006 groups3 employees language oxyrane.com

Registered entities

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace dormant. Cited 12 times.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Bank & private debt125%
Other / undisclosed125%
Coming soon